Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

N-2-(4-bromophenyl) ethyl caffeamide

Known as: N-(4-bromophenethyl)caffeamide, EK5 compound, N-(4-bromophenethyl)-3-(3,4-dihydroxyphenyl)acrylamide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Oxidative stress results in structural and functional abnormalities in the liver and is thought to be a crucial factor in liver… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
2016
2016
Overproduction of free radicals during ischemia/reperfusion (I/R) injury leads to an interest in using antioxidant therapy… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
BackgroundCoronary heart disease is a leading cause of death in the world and therapy to reduce injury is still needed. The… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
2011
2011
This report describes a model protein specifically tailored to electrochemically study the reduction potential of protein… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
2003
2003
BACKGROUND Caffeic acid phenylether ester (CAPE) has potent antioxidant, anti-inflammatory, antiviral, anti-proliferative… Expand
1995
1995
Let $\Phi:V\to V\otimes U$ be an intertwining operator between representations of a simple Lie algebra (quantum group, affine Lie… Expand
1983
1983
The effect of buffer type and pH, used in thymol test, was studied. Three methods for standardization of the test were compared… Expand